NPI: 1114981107 · PROVO, UT 84604 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,254 | $181K |
| 2019 | 11,471 | $253K |
| 2020 | 8,969 | $121K |
| 2021 | 6,794 | $102K |
| 2022 | 3,256 | $48K |
| 2023 | 114 | $1K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| A4657 | Syringe, with or without needle, each | 2,617 | 1,235 | $532K |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 8,605 | 1,455 | $88K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 14,804 | 969 | $50K |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,910 | 755 | $17K |
| 82728 | 807 | 551 | $10K | |
| J1756 | Injection, iron sucrose, 1 mg | 2,009 | 748 | $5K |
| 83540 | 804 | 548 | $3K | |
| 82108 | 194 | 144 | $2K | |
| 85041 | 1,419 | 958 | $751.92 | |
| 83550 | 772 | 519 | $25.14 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 203 | 106 | $0.00 |
| 90674 | 57 | 45 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 46 | 39 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 112 | 79 | $0.00 |
| 85048 | 1,392 | 945 | $0.00 | |
| 83970 | 1,053 | 705 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 54 | 39 | $0.00 |